Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GoPro Inc (GPRO) vs GSK plc (GSK) Price & Performance

Price performance (Past 24H)

Key statistics

GoPro Inc vs GSK plc — how do they compare? GoPro Inc trades at $0.58 (market cap $114.41M), while GSK plc trades at $50.33 (market cap $102.60B). The key difference: GSK plc is far larger — about 896.8× GoPro Inc's market cap, and GSK plc pays a 3.57% dividend while GoPro Inc pays none. Which is the better fit depends on your goals.

GPROGSK
Market Cap
$114.41M$102.60B
Sector
TechnologyHealth
52-Week High
$2.88$61.18
52-Week Low
$0.62$38.22
Enterprise Value
$173.19M$123.04B
Dividend Yield
3.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GoPro Inc

GoPro (GPRO) trades at $0.58, down 17.87% amid ongoing financial challenges. The company reported Q2 2026 revenue of $105 million with negative earnings, continuing a trend of revenue decline from $1.1B in 2022 to $652M in 2025. Technical indicators show bearish momentum with RSI at oversold levels, while fundamentals reveal negative net income margins and cash flow concerns despite low valuation multiples.

The outlook remains highly speculative with a strategic sale process underway. Investment opportunity exists only for event-driven speculators betting on acquisition potential, while significant risks include going concern warnings, persistent cash burn, and competitive pressures in the action camera market.

GSK plc

GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.

The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GoPro Inc

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.

Read more on GPRO

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK